Form 4: Oruka Therapeutics CEO Sells Shares
Insider Transaction (Form 4)
Lawrence Otto Klein, Chief Executive Officer and a Director of Oruka Therapeutics, Inc., sold 2,452 shares of common stock on September 15, 2026 for $95.71 per share.
Summary
- Open-market sale: disposed of 2,452 Common Stock at $95.71 ($234,681) on September 15, 2026; holds 923,128 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $234,681 of stock on the open market.
Insider Transactions
Lawrence Otto Klein — Director, Officer (Chief Executive Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-15 | Open-market sale | Common Stock | 2,452 | $96 | $234.7K | 923,128 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-15 | Open-market sale (2,452 shares) |
Keywords
insider transaction, Form 4, ORKA, Oruka Therapeutics, Inc., bearish, Lawrence Otto Klein
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.